[EN] ADENOSINE RECEPTOR MODULATORS<br/>[FR] MODULATEURS DE RECEPTEURS DE L'ADENOSINE
                        
                            
                                申请人:HOFFMANN LA ROCHE
                            
                            
                                公开号:WO2001062233A2
                            
                            
                                公开(公告)日:2001-08-30
                            
                            The invention relates to cyclic heteroaromatic compounds, containing at least one nitrogen atom, and to their use in the manufacture of medicaments for the treatment of diseases, related to adenosine receptor modulators, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, asthma, allergic responses, hypoxia, ischaemia, seizure, substance abuse, sedation and they may be active as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.